With more than 55 million people worldwide living with dementia (60-80% attributed to Alzheimer’s Disease), seven million of whom are in the U.S. and no current cure for Alzheimer’s or related disorders, the urgency to develop effective treatments only grows. Within the next 25 years, it is estimated that Alzheimer’s will affect nearly 14 million people in the U.S. alone. Efforts to continue to contribute towards scientific research and discovery are needed now more than ever to try to address this growing health crisis in Alzheimer’s Disease. Recently, the Yale School of Medicine received a gift from the Carol and Gene Ludwig Family Foundation to establish the Carol and Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia. This new interdepartmental initiative is designed to support neuroinflammation laboratory research, with an emphasis on neurodegenerative diseases, through the cultivation of innovative research and related activities with the promise for translation in the development of novel therapeutics and diagnostics. It will build upon established excellence in Neuroscience and in Immunobiology. By fostering neuroinflammation research at Yale, the program aims to build a community of accomplished faculty across Yale as well as to support recruitment of new talent in this nascent field. This position presents an outstanding opportunity for executive leadership of a new and priority program in the emerging field of neuroinflammation, aimed at tackling one of the most intractable medical challenges of our time.

As part of the creation of the Ludwig Program, the co-directors are searching for an Executive Director. The Executive Director of the Carol and Gene Ludwig Program for the Study of Neuroimmune Interactions in Dementia is responsible for overseeing the operations of the program. As the program’s administrative head, they will develop and implement strategic plans; design, run and evaluate programmatic activities, including the pilot grant programs; organize seminars and annual symposia; assist in the recruitment of world-class faculty and staff; and allocate and track affiliated resources. With proven and resourceful leadership, the Executive Director will coordinate the Program Advisory Committee of faculty leaders and external advisors, and the Program Award Committee of faculty leaders and external representatives. In coordination with the Program Co-Directors, the Executive Director will be the face of the program, representing the research and its societal impact through regular outreach to university constituencies, the local community, and the broader field. The Executive Director will be responsible for regular reporting and oversight, including donor relations and stewardship, and is expected to have earned a PhD in a relevant field with post-training experience.

For more information, contact ludwig.neuroimmune@yale.edu.

#J-18808-Ljbffr

Yale School of Medicine, Department of Neuroscience jobs

Executive Director, Ludwig Program for the Study of Neuroimmune Interactions in Dementia at Yale